{"id":52346,"date":"2022-12-27T12:02:08","date_gmt":"2022-12-27T11:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/clinical-microbiology-global-market-report-2022-industry-to-reach-5-7-billion-by-2027-at-a-6-5-cagr-researchandmarkets-com\/"},"modified":"2022-12-27T12:02:08","modified_gmt":"2022-12-27T11:02:08","slug":"clinical-microbiology-global-market-report-2022-industry-to-reach-5-7-billion-by-2027-at-a-6-5-cagr-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/clinical-microbiology-global-market-report-2022-industry-to-reach-5-7-billion-by-2027-at-a-6-5-cagr-researchandmarkets-com\/","title":{"rendered":"Clinical Microbiology Global Market Report 2022: Industry to Reach $5.7 Billion by 2027 at a 6.5% CAGR – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Clinical Microbiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global clinical microbiology market size reached US$ 3.9 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 5.7 Billion by 2027, exhibiting a CAGR of 6.53% during 2021-2027.\n<\/p>\n

\nClinical microbiology is a field of medical science that assists in diagnosing, preventing, and treating various infectious diseases. It focuses on identifying the presence of bacterial, viral, fungal, or parasitic agents and determining the susceptibility of microorganisms by conducting various tests. Some of the commonly used testing methods are direct smears and stains, cultures, molecular analysis, serological testing, and antibiotic susceptibility testing. Presently, clinical microbiology is gaining traction across the globe on account of its effective antibiotic administration and improved treatment outcomes.\n<\/p>\n

\nClinical Microbiology Market Trends:<\/strong>\n<\/p>\n

\nThe increasing prevalence of infectious diseases around the world represents one of the primary factors propelling the growth of the market. Additionally, the rising air and water pollution levels are increasing incidences of respiratory diseases among individuals, which, in turn, is driving the market. Apart from this, the integration of automation in clinical microbiology is creating a favorable outlook for market growth as it enables specimen traceability, eliminates delays in incubations and improves the efficiency of laboratory operations.\n<\/p>\n

\nFurthermore, the leading players are focusing on introducing technological advancements in disease diagnostics, such as the adoption of machine learning (ML), which aids in providing quick and accurate results. This, along with the introduction of several molecular diagnostic techniques, is offering lucrative growth opportunities to the market.\n<\/p>\n

\nMoreover, the rising adoption of advanced clinical diagnostic techniques, including real-time polymerase chain reaction (PCR), next-generation sequencing (NGS), and mass spectrometry for effective identification and characterization of pathogens, is acting as another growth-inducing factor. Other major factors, including the increasing number of new microorganisms causing various infectious diseases and the burgeoning healthcare sector across the globe, are anticipated to impel the growth of the market.\n<\/p>\n

\nKey Market Segmentation:<\/strong>\n<\/p>\n

\nThe publisher provides an analysis of the key trends in each sub-segment of the global clinical microbiology market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.\n<\/p>\n

\nBreakup by Product:<\/strong>\n<\/p>\n